Palomino Laboratories (PALX) Enterprise Value (2022 - 2025)

Palomino Laboratories has disclosed Enterprise Value across 4 years of filings, most recently posting -$8.1 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$8.1 million, down 5931.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.1 million (down 5931.21% YoY), and the FY2025 annual result was -$8.1 million, down 5931.21% from the prior year.
• Enterprise Value came in at -$8.1 million for Q4 2025 at Palomino Laboratories, down from -$7.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$322.0 in Q2 2024 to a low of -$8.1 million in Q4 2025.
• The 4-year median for Enterprise Value is -$500.0 (2022), against an average of -$1.3 million.
• Across the five-year window, Enterprise Value surged 35.6% in 2024 and slumped 2452250.62% in 2025, its largest moves.
• Palomino Laboratories' Enterprise Value stood at -$500.0 in 2022, then advanced by 24.0% to -$380.0 in 2023, then tumbled by 35336.05% to -$134657.0 in 2024, then sank by 5931.21% to -$8.1 million in 2025.
• The last three Enterprise Value figures came in at -$8.1 million (Q4 2025), -$7.9 million (Q3 2025), and -$1887.0 (Q2 2025), per Business Quant data.